Psychedelics: CEOs 15k Retreats or Justin's Take-Home?https://www.tricycleday.com/p/hate-say-microdosers-told
Return on investment: CEOs are spending $15k on mushroom retreats to become better leaders.
Here's why microdosing advocates are having their "I told you so" moment.
• Results that last: Three months after an 8-week LSD microdosing treatment, patients still showed a 62.8% reduction in depressive symptoms. (That’s not a typo, folks.)
• You can take it with you: Unlike other psychedelic pharma treatments, MindBio's approach lets patients self-administer at home. No tripsitter necessary.
• Ease of use: The trial showed "excellent safety, adherence, and tolerance." In human speak? Microdosing didn’t cause people problems, so they actually stuck with it.
• Budget friendly: CEO Justin Hanka claims this could be a "globally scalable, effective, affordable way to treat patients." (Gotta be cheaper than sitting with 2 therapists for 8 hours, right?)